|
시장보고서
상품코드
1671141
세계의 심장박동관리 기기 시장 규모, 점유율, 동향, 업계 분석 : 제품별, 지역별 - 시장 예측(2025-2034년)Cardiac Rhythm Management Devices Market Size, Share, Trends, Industry Analysis Report: By Products (Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices) and Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면, 세계 심장박동관리 기기 시장 규모는 2034년까지 319억 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.
심장박동관리 기기는 심박조율기, 제세동기 등 불규칙한 심장 박동을 모니터링하고 치료하는 데 사용되는 의료기기입니다. 심박조율기 시장은 심혈관질환의 유병률 증가, 인구 고령화, 심장 건강에 대한 인식 증가 등을 배경으로 크게 성장하고 있습니다. 주요 촉진요인으로는 무심장 기기, MRI 지원 기기, AI 기반 분석 등 환자의 결과와 편의성을 향상시키는 기기 기술의 발전을 들 수 있습니다. 비즈니스 기회는 의료 인프라가 개선되고 심장 질환에 대한 인식이 높아지는 신흥 지역에서의 시장 접근성 확대에 있습니다. 원격 모니터링, 웨어러블 기기, 최소침습적 시술 등의 트렌드가 시장을 형성하고 있으며, 합병증이 적은 심장 박동 장애를 관리하는 새로운 방법을 제공하고 있습니다. 전반적으로, 기술 혁신과 환자 치료 옵션의 개선으로 더 광범위한 도입과 더 나은 결과를 가져다 줄 수 있기 때문에 시장은 지속적으로 성장할 것으로 예상됩니다.
심장박동관리 기기 시장 : 분석 개요
제세동기는 생명을 위협하는 부정맥 치료에 중요한 역할을 하기 때문에 심장박동관리 기기 시장의 대부분을 차지하고 있습니다. 반면, 심장재동기화요법(CRT) 기기는 전 세계 심부전 유병률의 증가와 CRT 기술의 발전에 힘입어 가장 빠르게 성장하는 분야입니다.
북미가 가장 큰 시장 점유율을 차지하고 있는 것은 선진화된 의료 인프라, 높은 CRM 기기 보급률, 강력한 규제 당국의 지원 덕분입니다. 그러나 아시아태평양은 의료 접근성 향상, 고령화, 심혈관 건강에 대한 인식 증가에 힘입어 가장 높은 성장세를 보이고 있습니다.
목차
제1장 소개
제2장 주요 요약
제3장 분석 방법
제4장 심장박동관리 기기 시장 인사이트
- 시장 현황
- 심장박동관리 기기 시장 역학
- 성장 촉진요인과 기회
- 표적요법에 대한 관심 증대
- 면역요법의 진보
- 성장 억제요인과 과제
- 낮은 생존율
- 성장 촉진요인과 기회
- PESTLE 분석
- 심장박동관리 기기 시장 동향
- 밸류체인 분석
제5장 세계의 심장박동관리 기기 시장 : 제품별
- 주요 분석 결과
- 소개
- 페이스메이커
- 제세동기
- 심장재동기화치료
제6장 세계의 심장박동관리 기기 시장 : 지역별
- 주요 분석 결과
- 소개
- 심장박동관리 기기 시장 평가 : 지역별(2020-2034년)
- 북미
- 북미 : 제품별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 제품별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 제품별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 제품별(2020-2034년)
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 제품별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제7장 경쟁 구도
- 사업 확대·기업 인수 분석
- 사업 확대
- 기업 인수
- 제휴/협업/합의/공개
제8장 기업 개요
- Medtronic
- Abbott Laboratories
- Boston Scientific Corporation
- Biotronik SE & Co. KG
- MicroPort Scientific Corporation
- LivaNova PLC
- Koninklijke Philips N.V.
- Zoll Medical Corporation(a subsidiary of Asahi Kasei)
- Schiller AG
- Lepu Medical Technology
- Shree Pacetronix Ltd.
- EBR Systems
- Oscor Inc.
- Stryker Corporation
- Cardiac Science Corporation
The global cardiac rhythm management devices market size is expected to reach USD 31.90 billion by 2034, according to a new study by Polaris Market Research. The report "Cardiac Rhythm Management Devices Market Size, Share, Trends, Industry Analysis Report: By Products (Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy (CRT) Devices) and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Cardiac rhythm management devices are medical tools used to monitor and treat irregular heartbeats, such as pacemakers and defibrillators. The cardiac rhythm management devices market is experiencing significant growth, driven by the rising prevalence of cardiovascular diseases, an aging population, and increasing awareness of heart health. Key drivers include advancements in device technology, such as leadless pacemakers, MRI-compatible devices, and AI-driven analytics, which enhance patient outcomes and convenience. Opportunities lie in expanding market access in emerging regions, where healthcare infrastructure is improving and awareness of cardiac conditions is growing. Trends such as remote monitoring, wearable devices, and minimally invasive procedures are shaping the market, offering new ways to manage heart rhythm disorders with fewer complications. Overall, the market is poised for continued growth as technological innovations and improved patient care options lead to wider adoption and better outcomes.
Cardiac Rhythm Management Devices Market Report Highlights
Defibrillators dominate the cardiac rhythm management devices market due to their critical role in treating life-threatening arrhythmias. Meanwhile, cardiac resynchronization therapy (CRT) devices are the fastest-growing segment, driven by the increasing global prevalence of heart failure and advancements in CRT technology.
North America holds the largest market share, driven by advanced healthcare infrastructure, high adoption rates of CRM devices, and strong regulatory support. However, Asia Pacific is experiencing the highest growth, fueled by rising healthcare access, an aging population, and increasing awareness of cardiovascular health.
Polaris Market Research has segmented the cardiac rhythm management devices market report based on products and region:
By Products Outlook (Revenue-USD Billion, 2020 - 2034)
- Pacemakers
- Defibrillators
- Cardiac Resynchronization Therapy (CRT) Devices
By Regional Outlook (Revenue-USD Billion, 2020 - 2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Cardiac Rhythm Management Devices Market Insights
- 4.1. Cardiac Rhythm Management Devices Market - Market Snapshot
- 4.2. Cardiac Rhythm Management Devices Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increased Focus on Targeted Therapies
- 4.2.1.2. Advancements in Immunotherapy
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Low Survival Rates
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Cardiac Rhythm Management Devices Market Trends
- 4.6. Value Chain Analysis
5. Global Cardiac Rhythm Management Devices Market, by Products
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 5.3. Pacemakers
- 5.3.1. Global Cardiac Rhythm Management Devices Market, by Pacemakers, by Region, 2020-2034 (USD Billion)
- 5.4. Defibrillators
- 5.4.1. Global Cardiac Rhythm Management Devices Market, by Defibrillators, by Region, 2020-2034 (USD Billion)
- 5.5. Cardiac Resynchronization Therapy
- 5.5.1. Global Cardiac Rhythm Management Devices Market, by Cardiac Resynchronization Therapy, by Region, 2020-2034 (USD Billion)
6. Global Cardiac Rhythm Management Devices Market, by Geography
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Cardiac Rhythm Management Devices Market Assessment, By Geography, 2020-2034 (USD Billion)
- 6.3. Cardiac Rhythm Management Devices Market - North America
- 6.3.1. North America: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.3.2. Cardiac Rhythm Management Devices Market - US
- 6.3.2.1. US: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.3.3. Cardiac Rhythm Management Devices Market - Canada
- 6.3.3.1. Canada: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.4. Cardiac Rhythm Management Devices Market - Europe
- 6.4.1. Europe: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.4.2. Cardiac Rhythm Management Devices Market - UK
- 6.4.2.1. UK: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.4.3. Cardiac Rhythm Management Devices Market - France
- 6.4.3.1. France: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.4.4. Cardiac Rhythm Management Devices Market - Germany
- 6.4.4.1. Germany: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.4.5. Cardiac Rhythm Management Devices Market - Italy
- 6.4.5.1. Italy: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.4.6. Cardiac Rhythm Management Devices Market - Spain
- 6.4.6.1. Spain: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.4.7. Cardiac Rhythm Management Devices Market - Netherlands
- 6.4.7.1. Netherlands: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.4.8. Cardiac Rhythm Management Devices Market - Russia
- 6.4.8.1. Russia: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.4.9. Cardiac Rhythm Management Devices Market - Rest of Europe
- 6.4.9.1. Rest of Europe: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.5. Cardiac Rhythm Management Devices Market - Asia Pacific
- 6.5.1. Asia Pacific: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.5.2. Cardiac Rhythm Management Devices Market - China
- 6.5.2.1. China: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.5.3. Cardiac Rhythm Management Devices Market - India
- 6.5.3.1. India: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.5.4. Cardiac Rhythm Management Devices Market - Malaysia
- 6.5.4.1. Malaysia: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.5.5. Cardiac Rhythm Management Devices Market - Japan
- 6.5.5.1. Japan: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.5.6. Cardiac Rhythm Management Devices Market - Indonesia
- 6.5.6.1. Indonesia: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.5.7. Cardiac Rhythm Management Devices Market - South Korea
- 6.5.7.1. South Korea: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.5.8. Cardiac Rhythm Management Devices Market - Australia
- 6.5.8.1. Australia: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.5.9. Cardiac Rhythm Management Devices Market - Rest of Asia Pacific
- 6.5.9.1. Rest of Asia Pacific: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.6. Cardiac Rhythm Management Devices Market - Middle East & Africa
- 6.6.1. Middle East & Africa: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.6.2. Cardiac Rhythm Management Devices Market - Saudi Arabia
- 6.6.2.1. Saudi Arabia: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.6.3. Cardiac Rhythm Management Devices Market - UAE
- 6.6.3.1. UAE: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.6.4. Cardiac Rhythm Management Devices Market - Israel
- 6.6.4.1. Israel: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.6.5. Cardiac Rhythm Management Devices Market - South Africa
- 6.6.5.1. South Africa: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.6.6. Cardiac Rhythm Management Devices Market - Rest of Middle East & Africa
- 6.6.6.1. Rest of Middle East & Africa: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.7. Cardiac Rhythm Management Devices Market - Latin America
- 6.7.1. Latin America: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.7.2. Cardiac Rhythm Management Devices Market - Mexico
- 6.7.2.1. Mexico: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.7.3. Cardiac Rhythm Management Devices Market - Brazil
- 6.7.3.1. Brazil: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.7.4. Cardiac Rhythm Management Devices Market - Argentina
- 6.7.4.1. Argentina: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
- 6.7.5. Cardiac Rhythm Management Devices Market - Rest of Latin America
- 6.7.5.1. Rest of Latin America: Cardiac Rhythm Management Devices Market, by Products, 2020-2034 (USD Billion)
7. Competitive Landscape
- 7.1. Expansion and Acquisition Analysis
- 7.1.1. Expansion
- 7.1.2. Acquisitions
- 7.2. Partnerships/Collaborations/Agreements/Exhibitions
8. Company Profiles
- 8.1. Medtronic
- 8.1.1. Company Overview
- 8.1.2. Financial Performance
- 8.1.3. Product Benchmarking
- 8.1.4. Recent Development
- 8.2. Abbott Laboratories
- 8.2.1. Company Overview
- 8.2.2. Financial Performance
- 8.2.3. Product Benchmarking
- 8.2.4. Recent Development
- 8.3. Boston Scientific Corporation
- 8.3.1. Company Overview
- 8.3.2. Financial Performance
- 8.3.3. Product Benchmarking
- 8.3.4. Recent Development
- 8.4. Biotronik SE & Co. KG
- 8.4.1. Company Overview
- 8.4.2. Financial Performance
- 8.4.3. Product Benchmarking
- 8.4.4. Recent Development
- 8.5. MicroPort Scientific Corporation
- 8.5.1. Company Overview
- 8.5.2. Financial Performance
- 8.5.3. Product Benchmarking
- 8.5.4. Recent Development
- 8.6. LivaNova PLC
- 8.6.1. Company Overview
- 8.6.2. Financial Performance
- 8.6.3. Product Benchmarking
- 8.6.4. Recent Development
- 8.7. Koninklijke Philips N.V.
- 8.7.1. Company Overview
- 8.7.2. Financial Performance
- 8.7.3. Product Benchmarking
- 8.7.4. Recent Development
- 8.8. Zoll Medical Corporation (a subsidiary of Asahi Kasei)
- 8.8.1. Company Overview
- 8.8.2. Financial Performance
- 8.8.3. Product Benchmarking
- 8.8.4. Recent Development
- 8.9. Schiller AG
- 8.9.1. Company Overview
- 8.9.2. Financial Performance
- 8.9.3. Product Benchmarking
- 8.9.4. Recent Development
- 8.10. Lepu Medical Technology
- 8.10.1. Company Overview
- 8.10.2. Financial Performance
- 8.10.3. Product Benchmarking
- 8.10.4. Recent Development
- 8.11. Shree Pacetronix Ltd.
- 8.11.1. Company Overview
- 8.11.2. Financial Performance
- 8.11.3. Product Benchmarking
- 8.11.4. Recent Development
- 8.12. EBR Systems
- 8.12.1. Company Overview
- 8.12.2. Financial Performance
- 8.12.3. Product Benchmarking
- 8.12.4. Recent Development
- 8.13. Oscor Inc.
- 8.13.1. Company Overview
- 8.13.2. Financial Performance
- 8.13.3. Product Benchmarking
- 8.13.4. Recent Development
- 8.14. Stryker Corporation
- 8.14.1. Company Overview
- 8.14.2. Financial Performance
- 8.14.3. Product Benchmarking
- 8.14.4. Recent Development
- 8.15. Cardiac Science Corporation
- 8.15.1. Company Overview
- 8.15.2. Financial Performance
- 8.15.3. Product Benchmarking
- 8.15.4. Recent Development
